AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2019
Feb 28, 2019
32227_dirs_2019-02-28_4174eacc-71ca-408a-83c9-4faa3e04b20a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-02-26
Reporting Person: Bonello William (Chief Strategy Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-26 | Common Stock | M | 40166 | $8.03 | Acquired | 40166 | Direct |
| 2019-02-26 | Common Stock | M | 20037 | $7.52 | Acquired | 60203 | Direct |
| 2019-02-26 | Common Stock | S | 60203 | $18.90 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-26 | Stock Option (Right to Buy) | $8.03 | M | 40166 | Disposed | 2023-02-26 | Common Stock (40166.0) | Direct |
| 2019-02-26 | Stock Option (Right to Buy) | $7.52 | M | 20037 | Disposed | 2022-04-28 | Common Stock (20037.0) | Direct |
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24